The investigation of the ACE2/Ang 1-7/MasR axis as a potential therapeutic target in cardiovascular diseases, such as hypertension, has recently garnered significant interest in numerous research studies (28, 29). This evidence concerns the gene MAS1L and cardiovascular disorder.